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Abstract
The genetic locus causing autosomal domi-
nant retinitis pigmentosa (adRP) has recently
been mapped in a large English family to
chromosome 7p. Eight affected members of
this family were studied electrophysiologically
and psychophysically with dark adapted static
threshold perimetry and dark adaptometry.
The phenotypes observed feli into three
categories: minimaily affected with no symp-
toms, and normal (or near normal) electro-
physiology and psychophysics; moderately
affected with mild symptoms, abnormal
electroretinograms, and equal loss of rod and
cone function in affected areas of the retina;
and severely affected with extinguished
electroretinograms and barely detectable dark
adapted static threshold sensitivities. The
mutation in the gene on 7p causing adRP in this
family causes regional retinal dysfunction with
greatly variable expressivity ranging from
normal to profoundly abnormal in a manner
not explained by age.
(BrJ7 Ophthalmol 1995; 79: 23-27)
Inherited disorders causing photoreceptor
degeneration with nightblindness, reduced peri-
pheral vision, and preservation of central vision
until late are known collectively as retinitis
pigmentosa (RP).' RP may be inherited in an
autosomal dominant (adRP), autosomal reces-
sive, orX linked manner. The incidence ofRP in
the United Kingdom is approximately 1 in 5000,
with adRP accounting for 24% of families and
38% of cases.2
In adRP both allelic and non-allelic genetic
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Figure1 Abbreviatedfamily pedigree (see Inglehearn et al," Moore et al," and3Jay et al,20
for more details ofthis nine-generation family). Solid boxes or circles indicate affected males and
females, respectively. Horizontal notches indicate individuals studied in this report. Roman and
arabic numerals indicated respectively, generation and position numbers in refs 19 and 20.
heterogeneity exist." Mutations in the rhodop-
sin gene (RHO) on chromosome 3 account for
approximately 30% of adRP,'2 with over 50
mutations having been reported.'3 Mutations in
the gene encoding RDS-peripherin on chromo-
some 6 have also been implicated in adRP.9 14-' A
third locus has been provisionally mapped to
chromosome 88 and a fourth to chromosome 7q. '°
Recently, our group has mapped a fifth adRP
genetic locus to chromosome 7p."
In this report, we describe the electrophysio-
logical and psychophysical features of retinal
dysfunction in chromosome 7p-adRP" in
affected family members different from those
described in a previous study which used older
generation instrumentation.'9 We expand the
known range of phenotype expression observed
in chromosome 7p-adRP.
Methods
Some details of this large, nine generation
English family have been described pre-
viously." 1920 The severity of disease varied
widely between affected members. We studied
eight patients (Fig 1) with the haplotype on
chromosome 7p linked with adRP" who were
not studied previously.'9 They were selected on
the basis of having sufficient visual function to
warrant documentation using electrophysio-
logical and psychophysical techniques. The right
eye of each patient was studied. Patient details
are summarised in Table 1. Patients VIII-22,
VIII-23, and VIII-24 are siblings. Patient VII-45
is the mother of VIII-52.
Subjects underwent dark adapted electro-
retinographic testing (ERG) using a standard
protocol.2' Blue flashes were used for eliciting
rod dominant responses, red flashes for resolving
cone responses from rod responses, and white for
mixed cone and rod responses as well as cone
flicker responses. In contrast with our previous
study in which dark adapted static threshold
testing was performed at only 22 points without
dark adaptometry,'9 in this study both dark
adapted static threshold perimetry and dark
adaptometry were performed using a newer
Table I Patient characteristics
Subjective symptoms
Night Field
Patient Sex Age VA blind constriction
VIII-23 M 43 6/6 No No
VIII-24 M 45 6/6 No No
VIII-48 F 25 6/6 No No
VIII-22 F 46 6/6 Yes No
VII-45 F 51 6/6 Yes No
VIII-52 F 26 6/6 Yes No
VIII-42 F 38 6/12 Yes Yes
VII-32 M 49 6/6 Yes Yes
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Table 2 Flash electroretinographic results
White run 20*
Blue run 12* Red run 18* 30 Hzflicker*
b Wave b Wave a Wave b Wave b Wave
Subject Amp Imp Amp Imp Amp Imp Amp Imp Amp Imp
Normal mean 319 57 91 48 132 22 384 45 43 29
Normal limit 141 69 16 56 41 25 208 49 10 32
VIII-23 220 58 150 48 200 22 240 46 35 29
VIII-24 260 58 225 54 100 22 280 49 45 29
VIII-48 145 60 75 56 40 27 150 56 30 29
VIII-22 40 56 25 50 Flat 40 46 12 32
VII-45 Flat Flat Flat Flat Flat
VIII-52 Flat Flat Flat Flat Flat
VIII-42 Flat Flat Flat Flat Flat
VIII-32 Flat Flat Flat Flat Flat
*Refers to runs 12, 18, 20, and 30 (flicker) in Jay et al20. In run 18, only the cone b wave was measured.
Amp=amplitude in tV; Imp= implicit time in ms.
Normal limit=normal mean -2 SD for amplitude and normal mean +2 SD for implicit time.
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Figure 2 Dark adapted static threshold perimetryfor patients VIII-23 (A), V
VIII-48 (C). Average sensitivities in decibels (dB) with bars indicating range jindividuals are indicated on the greyscale at the bottom.
generation, modified Humphrey automated
perimeter.2223 Under dark adapted conditions
with dilated pupils, cone and rod sensitivities
were determined in an unlit bowl with size 5 red
and blue test stimuli, respectively, using a
standard 30-2 program. Two points were then
selected for dark adaptometry. Following
exposure to bright white light sufficient to bleach
95% of rhodopsin, the recovery of sensitivity to
size 5 blue test stimuli was followed over time.
Results
Patients VIII-23, VIII-24, and VIII-48 were all
asymptomatic. In one (VIII-48), the only abnor-
mality was a delayed and reduced ERG ampli-
tude to bright white flashes (Table 2), her other
ERG responses and sensitivities (Fig 2C and Fig
4A) being normal. In the other two, the results of
all functional tests were within normal limits
(Table 2, Fig 2A and 2B). These patients all had
scattered intraretinal bone spicule pigmentation
and the haplotype linked with chromosome 7p-
adRP.
Patients VIII-22, VII-45, and VIII-52 were
symptomatic with reduced ERG responses
(Table 2). Dark adapted static threshold peri-
metry revealed peripheral depression in cone and
rod mediated sensitivities which were affected in
the same areas to a similar degree with preserva-
tion of sensitivities centrally (Fig 3). These
individuals demonstrate regional24 or class 225
functional loss. While the final thresholds for the
cone and rod components of the dark adaptation
curve were elevated, the rates of dark adaptation
were normal (Fig 4B, C, and D).
Patients VIII-42 and VII-32 were severely
affected with symptoms of early onset,
extinguished ERG responses, and barely detect-
able dark adapted static perimetric sensitivities
(Fig 5). These individuals were too severely
affected to undergo dark adaptometry testing.
There is no recognisable pattern of severity of
disease in the families. There is no correlation of
the degree of functional loss between siblings or
between children and their parents or the sex of
the affected parent.
Discussion
By history alone, this family seems to exhibit
incomplete penetrance, with RP appearing to
'3Q0 'skip' generations.20 Assessment of penetrance,
however, varies with the level of ascertainment
and the sensitivity of testing systems in the
detection of retinal functional losses. In our
previous survey of different members of this
family,'9 we studied one asymptomatic obligate
carrier (VII-41) who exhibited reduced ampli-
tude electroretinographic responses and peri-
pheral constriction on Goldmann perimetry. On
this basis it was considered that there was
variable expressivity rather than incomplete
penetrance. Patients VIII-23, VIII-24, and
VIII-48 had minimal fundus changes; two of the
three lacked any delay in cone implicit times and
none had elevated dark adapted static perimetric
'III-24 (B), and rod thresholds, both of which have reported as
fornormal being sensitive indicators of mild retinal dys-
function.19 26 27 It is possible that these individuals
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Eigure 3 Dark adapted static threshold perimetryfor patients VIII-22 (A), VII45 (B.
VIII-52 (C). Average sensitivities in decibels (dB) with bars indicating rangefor normal
individuals are indicated on the greyscale at the bottom.
would have been indistinguishable from no
using currently available examination
niques had they been seen in the second or
decade of life at a time when genetic counse
is most important. Thus, this family highI
the potential difficulty in distinguishing bet
incomplete penetrance (an all or none phen
non) and variable expressivity (a gr
phenomenon).
The degree of retinal degeneration was
able in a manner not explained by age. The
patients studied varied from minimally aff
and asymptomatic with only scattered i
retinal bone spicules but normal ERG respi
and dark adapted psychophysics to sev
affected with extinguished electroretinog
and barely detectable dark adapted static
metric sensitivities. Between these two extr
were moderately affected members with ri
symptoms, reduced electroretinographic
responses, and psychophysical evidence of
regional24 or class 225 retinal functional loss, as
opposed to diffuse24 or class 125 functional loss.
The pattern of concentric, regional retinal
functional loss (Fig 3) differs from the regional
300 patterns seen in adRP associated with mutations
in the RHO gene.23 28-37 In all but one patient with
a rhodopsin mutation,23 the inferior retina was
preferentially compromised in an altitudinal dis-
tribution. The one exception was a RHO gene
insertion causing retinal functional loss greater
inferiorly but not in an altitudinal distribution.23
In addition to regional24 or class 225 retinal
functional loss, allelic mutations in the RHO
gene can cause diffuse24 or class 125 functional
loss.'3 Since many of the functional attributes of
rhodopsin are known,38 it is possible to formulate
hypotheses concerning the pathogenesis of
r300 disease. Although the genetic locus responsible
for adRP in this family has been mapped to the
short arm of chromosome 7," the responsible
gene has yet to be identified.
These families present a particular challenge
in genetic counselling since at a time at which
members are having children the phenotype may
not be recognisable. For this reason, it is not
possible to exclude the possibility of their having
affected children or of excluding genetic risk in a
member whose parents are apparently normal.
This is all the more important since mild disease
or a lack of disease in the parent does not
+ 300 preclude severe disease in the children. Know-
ledge of the locus of the causative gene allows
accurate counselling if the family is informative
for the available genetic markers. Once the
mutation is determined the genetic status could
be identified with certainty.
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Figure 4 Dark
adaptometry. Large circles
indicate patient responses;
small circlesfor age-matched
normals. Prebleach
measurements were made
before time 0. Two points
were evaluated based upon
the results ofdark adapted
static threshold perimetry
(Figs 1-3). (A) Patient
VIII48 was studied at
positions +9°, +9° (solid
circles) and -9°, - 90 (open
circles); (B) patient VIII-22
was studied at positions
- 9°, + 15° (solid circles) and
+9°,-15° (open circles);
(C) patient VII45 was
studied at positions
+ 15°, -15° (solid circles)
and -15°,+15° (open
circles); (D) patient VIII-52
was studied at positions
- 3°, +9° (solid circles) and
-90,00 (open circles).
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Figure S Dark adapted static threshold perimetryfor patients VIII42 (A) and VII-32 (.
Average sensitivities in decibels (dB) with bars indicating rangefor normal individuals areindicated on the greyscale at the bottom.
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